Eli Lilly (LLY) EVP Custer receives 659-share equity award at $1,044.67

Rhea-AI Filing Summary

Eli Lilly executive Kenneth L. Custer reported an equity award of company stock. On 02/09/2026, he acquired 659.28 shares of Eli Lilly common stock as a grant or award at a value of $1,044.67 per share. Following this non‑open‑market acquisition, he directly holds 10,024.855 Eli Lilly shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Custer Kenneth L.

(Last) (First) (Middle)

LILLY CORPORATE CENTER

(Street)

INDIANAPOLIS IN 46285

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ELI LILLY & Co [ LLY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & President, Card Met Hlth

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/09/2026		A		659.28	A	$1,044.67	10,024.855	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Jonathan Groff for Kenneth Custer, pursuant to authorization on file	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Eli Lilly (LLY) executive Kenneth Custer report?

Kenneth L. Custer reported an acquisition of Eli Lilly common stock through an equity award. He received 659.28 shares as a grant on 02/09/2026, rather than buying shares in the open market, reflecting compensation in stock form.

How many Eli Lilly (LLY) shares did Kenneth Custer acquire and at what value?

Kenneth Custer acquired 659.28 Eli Lilly common shares via a grant. The filing values this equity award at $1,044.67 per share, documenting the price used to calculate the award’s size for reporting and compensation disclosure purposes.

What is Kenneth Custer’s total Eli Lilly (LLY) shareholdings after this Form 4?

After the reported equity award, Kenneth Custer beneficially owns 10,024.855 Eli Lilly common shares. The filing shows this figure as his direct ownership total following the 659.28‑share grant on 02/09/2026, all held in direct form.

Was Kenneth Custer’s Eli Lilly (LLY) transaction a market purchase or an award?

The transaction was an equity award, not an open‑market purchase. The Form 4 uses transaction code A, described as a grant, award, or other acquisition, indicating these 659.28 shares were received as part of his compensation package.

What role does Kenneth Custer hold at Eli Lilly (LLY) in this Form 4 filing?

Kenneth L. Custer is identified as an officer of Eli Lilly, serving as EVP & President, Card Met Hlth. The Form 4 links this insider equity award and his reported beneficial ownership directly to his senior leadership position at the company.